The enrollment growth of Medicare Advantage plans has experienced a significant slowdown, with only a 3.1% increase from 2024 to 2025, according to recent...
Lower-Priced Vials of Zepbound Drug Offer Hope for Patient AccessIn a groundbreaking move last year, Eli Lilly introduced lower-priced vials of its popular obesity...